Utah Medical Products, Inc.UTMDNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -25.74% | -14.37% | -4.30% | -1.93% | -1.24% |
| Gross Profit Growth | -25.01% | -18.15% | -11.96% | -4.11% | -11.12% |
| EBITDA Growth | -29.24% | -21.23% | -6.59% | -17.42% | -3.34% |
| Operating Income Growth | -25.71% | -18.80% | -7.04% | -21.90% | -16.66% |
| Net Income Growth | -32.29% | -23.13% | -11.73% | -26.16% | -11.61% |
| EPS Growth | -27.12% | -15.60% | -3.16% | -22.55% | -10.47% |
| EPS Diluted Growth | -27.12% | -15.60% | -4.08% | -19.61% | -6.98% |
| Weighted Average Shares Growth | -6.64% | -8.55% | -8.55% | -4.83% | -2.30% |
| Weighted Average Shares Diluted Growth | -6.64% | -8.51% | -8.10% | -7.79% | -5.61% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -44.92% | -15.39% | +4.02% | +0.57% | -100.00% |
| Free Cash Flow Growth | -44.14% | -18.54% | +6.61% | -3.56% | -100.00% |
| Receivables Growth | +20.77% | +9.83% | -0.98% | +0.13% | -13.97% |
| Inventory Growth | -8.04% | -6.41% | -9.11% | -10.86% | -9.95% |
| Asset Growth | -9.54% | -9.54% | -7.10% | -5.95% | +0.00% |
| Book Value per Share Growth | -1.97% | +0.19% | +3.60% | +0.05% | +3.96% |
| Debt Growth | -4.41% | -5.61% | -6.91% | -19.40% | -20.21% |
| R&D Expense Growth | -17.12% | -41.73% | -47.06% | -2.91% | +75.21% |
| SG&A Expenses Growth | -31.19% | +3.89% | -15.85% | +29.51% | -72.66% |